Article ID Journal Published Year Pages File Type
8236341 International Journal of Radiation Oncology*Biology*Physics 2009 7 Pages PDF
Abstract
CA 19-9 decline shows a correlation with radiologic response. The combination of pretreatment CA 19-9 >1,200 U/mL, posttreatment CA 19-9 >100 U/mL, and CA 19-9 decline ≤40% may possibly serve as a surrogate marker for poor survival in advanced PC receiving chemoradiotherapy.
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Authors
, , , , ,